$2.33T
Total marketcap
$81.72B
Total volume
BTC 50.01%     ETH 15.35%
Dominance

Acro Biomedical ACBM Stock

0.11 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
6.3M USD
LOW - HIGH [24H]
0.11 - 0.11 USD
VOLUME [24H]
300 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.25 USD

Acro Biomedical Price Chart

Acro Biomedical ACBM Financial and Trading Overview

Acro Biomedical stock price 0.11 USD
Previous Close 2 USD
Open 2 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 2 - 2 USD
52 Week Range 1.68 - 4.5 USD
Volume 100 USD
Avg. Volume 495 USD
Market Cap 120.08M USD
Beta (5Y Monthly) 0.95672
PE Ratio (TTM) N/A
EPS (TTM) -0.25 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

ACBM Valuation Measures

Enterprise Value 100.96M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 133.94757
Price/Book (mrq) 249.99998
Enterprise Value/Revenue 112.621
Enterprise Value/EBITDA N/A

Trading Information

Acro Biomedical Stock Price History

Beta (5Y Monthly) 0.95672
52-Week Change -52.94%
S&P500 52-Week Change 20.43%
52 Week High 4.5 USD
52 Week Low 1.68 USD
50-Day Moving Average 3.14 USD
200-Day Moving Average 3.71 USD

ACBM Share Statistics

Avg. Volume (3 month) 495 USD
Avg. Daily Volume (10-Days) 170 USD
Shares Outstanding 60.04M
Float 30.04M
Short Ratio N/A
% Held by Insiders 49.96%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 3:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) September 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 0%
Operating Margin (ttm) -1761.12%
Gross Margin 25.26%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -1549.74%
Return on Equity (ttm) -2978.091%

Income Statement

Revenue (ttm) 896.5K USD
Revenue Per Share (ttm) 0.02 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 259.5K USD
EBITDA N/A
Net Income Avi to Common (ttm) -15789575 USD
Diluted EPS (ttm) -0.18
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 16.19K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 110.58K USD
Total Debt/Equity (mrq) 22.47 USD
Current Ratio (mrq) 4.19
Book Value Per Share (mrq) 0.008

Cash Flow Statement

Operating Cash Flow (ttm) -197419 USD
Levered Free Cash Flow (ttm) 5.73M USD

Profile of Acro Biomedical

Country United States
State IN
City Fishers
Address 12175 Visionary Way
ZIP 46038
Phone 317 286 6788
Website https://acrobiomedicalco.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

Q&A For Acro Biomedical Stock

What is a current ACBM stock price?

Acro Biomedical ACBM stock price today per share is 0.11 USD.

How to purchase Acro Biomedical stock?

You can buy ACBM shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Acro Biomedical?

The stock symbol or ticker of Acro Biomedical is ACBM.

Which industry does the Acro Biomedical company belong to?

The Acro Biomedical industry is Biotechnology.

How many shares does Acro Biomedical have in circulation?

The max supply of Acro Biomedical shares is 60.04M.

What is Acro Biomedical Price to Earnings Ratio (PE Ratio)?

Acro Biomedical PE Ratio is now.

What was Acro Biomedical earnings per share over the trailing 12 months (TTM)?

Acro Biomedical EPS is -0.25 USD over the trailing 12 months.

Which sector does the Acro Biomedical company belong to?

The Acro Biomedical sector is Healthcare.